Advancements in upstream CLD for enhanced biotherapeutics production
Drug Discovery World
NOVEMBER 27, 2023
By Anis H Khimani , PhD, Senior Strategy Leader, Life Sciences strategy group, Revvity, Inc. Upstream cell line development has seen notable progress with recent advances in cell line engineering, particularly in enhancing gene of interest integration specificity, clone selection, and production efficiency.
Let's personalize your content